The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180: 7938-7947.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kedzierska, K.
Right arrow Articles by Doherty, P. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kedzierska, K.
Right arrow Articles by Doherty, P. C.

Homogenization of TCR Repertoires within Secondary CD62Lhigh and CD62Llow Virus-Specific CD8+ T Cell Populations1

Katherine Kedzierska2,*, Vanessa Venturi{dagger}, Sophie A. Valkenburg*, Miles P. Davenport{dagger}, Stephen J. Turner* and Peter C. Doherty*,{ddagger}

* Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria; {dagger} Department of Haematology, Prince of Wales Hospital and Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia; and {ddagger} Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105

Influenza virus-specific CD8+ T cell clonotypes generated and maintained in C57BL/6J mice after respiratory challenge were found previously to distribute unequally between the CD62Llow "effector" (TEM) and CD62Lhigh "central" (TCM) memory subsets. Defined by the CDR3β sequence, most of the prominent TCRs were represented in both the CD62Lhigh and CD62Llow subsets, but there was also a substantial number of diverse, but generally small, CD62Lhigh-only clonotypes. The question asked here is how secondary challenge influences both the diversity and the continuity of TCR representation in the TCM and TEM subsets generated following primary exposure. The experiments use single-cell RT-PCR to correlate clonotypic composition with CD62L phenotype for secondary influenza-specific CD8+ T cell responses directed at the prominent DbNP366 and DbPA224 epitopes. In both the acute and long-term memory phases of the recall responses to these epitopes, we found evidence of a convergence of TCR repertoire expression for the CD62Llow and CD62Lhigh populations. In fact, unlike the primary response, there were no significant differences in clonotypic diversity between the CD62Llow and CD62Lhigh subsets. This "TCR homogenization" for the CD62Lhigh and CD62Llow CD8+ populations recalled after secondary challenge indicates common origin, most likely from the high prevalence populations in the CD62Lhigh central memory set. Our study thus provides key insights into the TCR diversity spectrum for CD62Lhigh and CD62Llow T cells generated from a normal, unmanipulated T cell repertoire following secondary challenge. A better understanding of TCR selection and maintenance has implications for improved vaccine and immunotherapy protocols.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by an Australian National Health and Medical Research Council Burnet Fellowship and the National Institutes of Health Grant AI70251 awarded to P.C.D. and a National Health and Medical Research Council Project Grant 454312 awarded to K.K. S.J.T. is a Pfizer Senior Research Fellow, M.P.D. is a Sylvia and Charles Viertel Senior Medical Research Fellow, and K.K. is a National Health and Medical Research Council R. D. Wright Research Fellow.

2 Address correspondence and reprint requests to Dr. Katherine Kedzierska, University of Melbourne, Royal Parade, Parkville, Victoria 3010, Australia. E-mail address: kkedz{at}unimelb.edu.au

3 Abbreviations used in this paper: TCM, central memory T cell; TEM, effector memory T cell; H, viral hemagglutinin molecule; N, viral neuraminidase; i.n., intranasally; PR8, A/PR/8/34 H1N1 influenza virus; HKx31, A/HKx31 H3N2 influenza virus.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.